Thu, November 9, 2023
Wed, November 8, 2023
Tue, November 7, 2023

Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $6 on, Nov 8th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-6-on-nov-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $7 to $6 on, Nov 8th, 2023.

Gregory has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 2 agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Cheng of "JP Morgan" Upgraded from Sell to Hold on, Thursday, August 10th, 2023
  • Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $5 on, Tuesday, July 11th, 2023


This is the rating of the analyst that currently disagrees with Gregory


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Tuesday, September 19th, 2023

Publication Contributing Sources